For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT?
1
2 AnswersMednet Member
Pediatric Hematology/Oncology · Children’s Wisconsin
It is true that on the clinical trial AHOD1331, patients who presented with large mediastinal adenopathy received radiation therapy as did patients who were slow early responders (Deauville 4 or 5 after two cycles of therapy). It is noteworthy that 3-year event-free survival was extremely high for a...
Mednet Member
Pediatric Hematology/Oncology · University of Saskatchewan
Excellent question.
Dr. @Dr. First Last's answer above is informative particularly the remarkable rates of radiation with N-AVD of 0.4%, while maintaining excellent outcomes. That is a preferred approach compared to what I will say next.
The only addition I have: I had a patient with stage IIB with b...